Replacing genome variant annotation, filtering and interpretation software
Expired
The competition has expired without a winner being announced.
- Deadline
- Jun 8,Expired
- Award
- Price 30% and 1 more
Brief
Stichting Amsterdam UMC needs medical software for replacing genome variant annotation, filtering, and interpretation over 8 years, with a maximum total value of 2,360,000 EUR. The software will process VCF files from a bioinformatics pipeline, annotate and filter variants based on laboratory-defined criteria, and support interpretation using various tools/databases, including an AI tool for identifying causal variants. It will be used by approximately 200 personnel for diagnostic and research purposes. Award criteria include "Annex I9b Program of Requirements Functional and list of wishes" (28%), "Usecases" (42%), and "Price" (30%).
Programvareprodukter og lisenser
Custom Assessment Criteria
Get answers to your bid/no-bid criteria
Set them up once and Cobrief answers them in every tender
Will you bid?
The agent sets up the bid and writes the first draft. Free for 14 days.
Award Criteria
Description
annex I9C
Source
No source found in the documents. Check the weight against the tender documents.
Description
see i9d & i9e
Source
No source found in the documents. Check the weight against the tender documents.
Description
This documents contains wishes where points can be won.
Source
No source found in the documents. Check the weight against the tender documents.
Previous winners
Who are you up against?
The suppliers who have won similar contracts at Stichting Amsterdam UMC
From the notice
Data from the sequencer is processed through a bioinformatics pipeline (currently GATK, soon transitioning to DRAGEN), which outputs all possible variants relative to the reference genome in tabular form in a VCF file. This VCF file is imported into the software, where annotation first takes place: all valid variants are separated from invalid variants based on quality parameters. Because this results in a large number of variants, they are subsequently filtered based on laboratory defined criteria, such as genomic position, population frequency, known pathogenicity based on literature or insilico prediction tools. All remaining variants must then be interpreted using various tools/databases. The software supports the use and visualisation of data from these tools, enabling fast and efficient interpretation — including through an AI tool that proposes the most likely causal variant for the disorder. software will be used by more or less 200 personel for diagnostics and research purposes. estimated value is based on 8 years
Contact
Rick van den DolderR.vandenDolder@amterdamUMC.nl- CompetitionType
- 48180000Main codeMedical software package